Home › Funds › MPM BioImpact LLC › TRVI

MPM BioImpact LLC position in TRVI

TREVI THERAPEUTICS INC · Health Care

MPM BioImpact LLC reported holding 3,073,577 shares of TRVI (TREVI THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$57.3M, representing 3.50% of its reported portfolio and ranking #9 among its reported holdings. MPM BioImpact LLC has disclosed TRVI holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)3.07M sh
Reported value held$57.32M
Portfolio Weight3.50%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's TRVI position evolved

MPM BioImpact LLC first disclosed a stake in TRVI in Q1 2024 at 1,340,960 shares (US$4.6M). The position peaked in Q2 2026 at 3,073,577 shares, worth US$57.3M. Across 10 filings, MPM BioImpact LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 3,073,577 shares valued at US$57.3M — a reduction of -224,853 shares quarter over quarter.. Notable position changes include a 101% increase in Q4 2024 (shares rose 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.34M $4.63M New
Q2 2024 1.51M $4.50M Add
Q3 2024 1.54M $5.14M Add
Q4 2024 3.09M $12.75M Add
Q1 2025 3.43M $21.56M Add
Q2 2025 3.41M $18.64M Reduce
Q3 2025 3.41M $31.17M Hold
Q4 2025 3.29M $41.15M Reduce
Q1 2026 3.30M $39.35M Hold
Q2 2026 3.07M $57.32M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has MPM BioImpact LLC held TRVI?

MPM BioImpact LLC has disclosed TRVI holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is MPM BioImpact LLC's current position in TRVI?

As of Q2 2026, MPM BioImpact LLC holds 3.07M shares of TRVI (TREVI THERAPEUTICS INC), valued at $57.32M, representing 3.50% of its reported portfolio and ranking #9.

Has MPM BioImpact LLC been buying or selling TRVI?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in TRVI. The position peaked in Q2 2026 at 3.07M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.